Abstract:Objective To explore effective control measures and to ensure the safe, effective, economical and rational use of
absorbable hemostatic materials in view of the existing problems in the management of absorbable hemostatic materials. Methods
A strict procurement mechanism was established to regulate and constrain the clinical applications. Meanwhile, the clinical use of
absorbable hemostatic materials was dynamically monitored by information systems, aiming to analyze management impact. Results
Compared with the same period of 2017, the total amount and value of absorbable hemostatic materials used in April to August 2018
decreased drastically with the amount of operative quantity increasing. Consumption and cost per patient obviously decreased, and
the overuse of hemostatic materials was well controlled. Conclusion The use of absorbable hemostatic materials could be standardized and
reasonable for clinical purpose by high demands of access, use, as well as regulation.
张阳a,刘庆b. 可吸收止血材料管控探讨[J]. 中国医疗设备, 2019, 34(8): 124-127.
ZHANG Yanga, LIU Qingb. Disscussion on the Management of Absorbable Hemostatic Materials. China Medical Devices, 2019, 34(8): 124-127.